AlphAIAlphAI — Financial news for AI agents
tradingview.com$RHEP

Regional Health Properties 3Q 2026: Revenue $25.01M, EPS ($0.22) — 10-Q Summary

Regional Health Properties reported 3Q 2026 revenue of $25.01M, up 65.2% YoY, driven by Pharmacy Services and Healthcare Services growth. Net income turned to a loss of $851K from a $3.66M profit. EPS was ($0.22) compared to $1.17. Revenue growth included contributions from the SunLink merger and facility transitions.

Original reporting
tradingview.com
Published Nov 13, 2026, 11:31 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 13, 2026, 11:42 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Regional Health Properties 3Q 2026: Revenue $25.01M, EPS ($0.22) — 10-Q Summary — source image
Source · tradingview.com
Decision brief

The 30-second read

$RHEPBearishLow
01

Why it matters

The earnings miss may trigger a short‑term decline, but the merger‑driven growth could be a catalyst for future recovery.

02

Market read

Micro‑cap REIT earnings release with mixed signals; likely short‑term downside.

03

What to watch

Potential upside from the pending sale of Meadowood property at $4M, which may offset the $0.5M impairment.

Relevance 6/10Novelty 6/10Timing: post‑market release

Background

Regional Health Properties filed its Q3 2026 10‑Q, reporting a sharp revenue increase but a swing to loss after a recent merger.

Company-level read

Ticker impact

$RHEPBearishHigh confidence
Context

10-Q shows revenue up 65% YoY but a swing to a $0.22 loss per share and a $851K net loss.

Expected impact

downward pressure as investors price in the loss and impairment

Evidence & confidence

The surprise loss and impairment are fresh disclosures that can trigger a sell-off.

Market effects

Sector

Highlights volatility in the healthcare‑real‑estate niche after a merger‑driven revenue mix shift.

Regional

Limited to U.S. REIT investors; no broader market effect.

Global

Minimal

Counterpoint

What could challenge this read

The revenue surge from the SunLink merger could support a longer‑term upside if the integration succeeds.

Key entities

  • company
    Regional Health Properties, Inc.

    Healthcare‑focused REIT that reported Q3 2026 results.

Read at source← All news

Related articles

$BTOMedAI 8/10

B2Gold Earnings Call Signals Lower Costs and Growth

B2Gold Corp. reported Q3 earnings with strong production, lower cost guidance, and positive free cash flow. The company produced 193,000 ounces of gold, reduced all-in sustaining cost guidance by over $100 per ounce, and generated $48 million in free cash flow. Revenue reached $836 million, supported by higher gold prices. The company also highlighted growth projects and shareholder returns.

tipranks.com
$NMAXMed

Why Newsmax Stock Popped on Friday

Newsmax (NMAX) shares rose 31% after reporting Q3 revenue of $69M, up 52.5% YoY, and net income of $15.2M. The company cited strong audience engagement and growth in high-margin revenue streams. CEO Christopher Ruddy expects continued growth ahead of the presidential election.

finance.yahoo.com
$LUNRMed

What Is Driving Intuitive Machines Stock?

Intuitive Machines (LUNR) shares rose 7.0% on Nov 12, 2026, after reporting Q3 revenue of $269M, beating estimates. The company's loss of $0.10 per share met expectations, while gross margin improved to 26%. Free cash flow turned positive at $33M, a company record. Management raised full-year revenue guidance to $920M-$950M. The stock's performance contrasted with broader industry declines.

finance.yahoo.com
$RMIXMedAI 8/10

Suncrete (RMIX) Q3 2026 Earnings Call Transcript

Suncrete (RMIX) reported Q3 2026 revenue of $141M, up 45% QoQ and 163% YoY. Adjusted EBITDA rose 66% QoQ to $22.4M. The company lowered its full-year outlook due to residential construction weakness but remains confident in long-term demand. Acquisition integration is progressing, with North Texas showing margin improvement. Suncrete expects $200M-$250M revenue from 2026 acquisitions in 2027. The company has $206.5M in total liquidity.

finance.yahoo.com
$CLLSMed

Cellectis SA (CLLS) (Q3 2026) Earnings Call Highlights: Strategic Shift to Gene

Cellectis SA (CLLS) discussed its strategic shift to gene editing during its Q3 2026 earnings call. Management highlighted the selection of APOC3 over ANGPTL3 for triglyceride reduction, with plans to start Phase 1 dosing by end-2027. The company reported $149M in cash as of September 30, 2026, with a runway into H2 2028. Revenue decreased to $19.9M from $67.4M YoY, while R&D expenses increased to $108.8M from $69.1M, driven by the AstraZeneca collaboration.

finance.yahoo.com
$YTRAMed

Yatra Online Inc (YTRA) (Q2 2027) Earnings Call Highlights: Air and Corporate Travel

Yatra Online (YTRA) reported Q2 2027 revenue from operations down 39% YoY to INR2,136M (~$22M) due to lower MICE volumes. Gross margin stayed flat at INR1,255M (~$13M). Adjusted EBITDA swung to negative INR32M (~negative $0.3M). CEO Gupta noted MICE recovery signs, TravelPro and Recap initiatives progress, and AI efficiency gains. Standalone hotels grew 20% YoY. H1 FY27 revenue declined 28% YoY to INR4,015M (~$42M).

finance.yahoo.com